Cosmetic & Longevity

Thymosin Alpha-1

Price range: $75.00 through $120.00
99%+ Purity Third-Party Tested CoA Included
Jump to COA
Select size and quantity
SKU: Sizes: 5MG • 10MG
Fast COA access
Clean product layout
Variation-ready

Product Description

Thymosin Alpha-1 | Research Use Only

What it is

Thymosin Alpha-1, also known as Tα1 or thymalfasin, is a naturally occurring 28-amino-acid peptide originally isolated from thymus tissue and widely studied for its immunomodulatory activity. In the scientific literature, it is described as an endogenous peptide involved in immune regulation, which is why it is commonly used in immunology and cell-signaling research.

Origins and scientific context

Thymosin Alpha-1 is not a random synthetic analog but a laboratory-produced form of a naturally occurring thymic peptide. Reviews describe it as an N-terminally acetylated 28-residue peptide first characterized from calf thymus extracts, with later research expanding its use as a tool for studying immune-cell activation, cytokine regulation, and host-response pathways.

Molecular profile

PubChem lists Thymalfasin as Thymosin Alpha-1 and identifies it as an acetylated polypeptide. The literature consistently describes Tα1 as a 28-amino-acid peptide, and PubChem records it under the compound name Thymalfasin.

Scientific overview

In simplified terms, Thymosin Alpha-1 is used in research to study immune modulation, innate and adaptive immune signaling, and host-response regulation. Reviews report that Tα1 can influence T-cell, dendritic-cell, and cytokine-associated pathways and has been investigated across infectious disease, inflammation, and immune-restoration models.

What researchers study with Thymosin Alpha-1

Key research focus areas often include
• T-cell and dendritic-cell signaling pathways
• Cytokine and chemokine regulation
• Innate and adaptive immune-response models
• Viral infection and immune-restoration research contexts

Regulatory and compliance notice

Research Use Only. Not for human or veterinary use. This description is provided for scientific context and must not be used to market Thymosin Alpha-1 for diagnosis, cure, mitigation, treatment, or prevention of disease. Current literature describes it as an investigational immunomodulatory peptide in research and clinical literature.

Citations and references

PubChem compound entry for Thymalfasin, identifies Thymosin Alpha-1 as an acetylated polypeptide.

Dominari et al. Thymosin alpha 1: A comprehensive review of the literature, review describing Thymosin Alpha-1 as a naturally occurring thymic peptide with immune-modulating activity.

Li et al. Thymosin alpha 1: Biological activities, applications and genetic engineering production, review describing Tα1 as a 28-amino-acid peptide first characterized from thymus tissue.

Tao et al. Thymosin α1 and Its Role in Viral Infectious Diseases, review covering immune-cell and Toll-like-receptor-related research context for Tα1.

Binder et al. PASylated Thymosin α1: A Long-Acting Immunostimulatory Polypeptide Conjugate, paper describing Tα1 as an N-terminally acetylated 28-residue peptide.

COA Testing

The Certificate of Analysis for this product is shown directly below for easier review.

Certificate of Analysis coming soon

COA will display here once attached.